Does RALTEGRAVIR Cause Lipodystrophy acquired? 153 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 153 reports of Lipodystrophy acquired have been filed in association with RALTEGRAVIR (ISENTRESS). This represents 1.8% of all adverse event reports for RALTEGRAVIR.
153
Reports of Lipodystrophy acquired with RALTEGRAVIR
1.8%
of all RALTEGRAVIR reports
0
Deaths
25
Hospitalizations
How Dangerous Is Lipodystrophy acquired From RALTEGRAVIR?
Of the 153 reports, 25 (16.3%) required hospitalization, and 11 (7.2%) were considered life-threatening.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RALTEGRAVIR. However, 153 reports have been filed with the FAERS database.
What Other Side Effects Does RALTEGRAVIR Cause?
Foetal exposure during pregnancy (1,033)
Maternal exposure during pregnancy (726)
Exposure during pregnancy (700)
Drug interaction (552)
Virologic failure (517)
Depression (482)
Death (431)
Pathogen resistance (425)
Drug resistance (388)
No adverse event (339)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which RALTEGRAVIR Alternatives Have Lower Lipodystrophy acquired Risk?
RALTEGRAVIR vs RALTITREXED
RALTEGRAVIR vs RAMELTEON
RALTEGRAVIR vs RAMIPRIL
RALTEGRAVIR vs RAMUCIRUMAB
RALTEGRAVIR vs RANEXA